@article{14b6ef7ee8144effae1d16a1d49aceb1,
title = "The 50th Anniversary of the American Pancreatic Association and Japan Pancreas Society: The Vay Liang and Frisca Go Award for Lifetime Achievement and the Distinguished Service Award",
author = "Saluja, {Ashok K.} and Carney, {Jennifer B.} and Torres, {Veronica S.} and Go, {Vay Liang W.}",
note = "Funding Information: Over the past 20 years, he and his team have studied the intricate, multidirectional association between diabetes and pancreatic cancer with a goal to develop a rational, evidence-based strategy to detect presymptomatic sporadic pancreatic cancer. Since 2003, this work has been funded by the National Institutes of Health. A series of studies by his group and others have now established that pancreatic cancer causes a paraneoplastic diabetes, likely mediated through exosomes shed by pancreatic cancer. In a recent editorial, diabetes induced by pancreatic cancer was called an “exosomopathy,” the first disease to be caused by exosomes. Currently, he is the principal investigator of Mayo Clinic's U01 Consortium on Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer (CPDPC), a co-investigator in Pancreatic Cancer Detection Consortium (U01), and a member of the Steering Committee of the Early Detection Initiative, a collaborative effort among National Cancer Institute (NCI), Pancreatic Cancer Action Network, and CPDPC to launch an early detection protocol for pancreatic cancer.",
year = "2019",
month = nov,
day = "1",
doi = "10.1097/MPA.0000000000001418",
language = "English (US)",
volume = "48",
pages = "1242--1245",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "10",
}
